Watch This | Collaborative model of Internet entrepreneurship promotes ALS drug research and development

The process of developing a new drug is incredibly challenging and lengthy. Worldwide, there is limited investment in the development of drugs for rare diseases. Due to the substantial investment required, the low potential for high returns, and the extended timeline, many pharmaceutical companies are reluctant to engage in ALS drug development. In order to encourage more pharmaceutical and biotechnology companies to invest in ALS drug research, Cai Lei has adopted a collaborative internet entrepreneurial model that has significantly transformed the collaborative approach to rare disease drug development.